ANDS Financial Facts
Gain from valuation of common stock warrant liability: 497KTotal other income, net: 523K
See Full Income Statement
Prepaid expenses and other current assets: 902K
Other long-term liabilities: 1K
See Full Balance Sheet
Anadys Pharmaceuticals Inc. (ANDS) Earnings
|
Expand Research on ANDS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +3.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +48.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/7/11 | Q311 | -$0.16 | -$0.14 | -$0.02 | N/A | N/A | N/A |  | | Details | |
8/8/11  |
 |
Q211 | -$0.14 | -$0.11 | -$0.03 | N/A | N/A | N/A | | | Details |
| 5/5/11 |
Q111 | -$0.10 | -$0.10 | $0.00 | N/A | N/A | N/A | | | Details | |
| 3/3/11 |
|
Q410 | -$0.04 | -$0.09 | +$0.05 | N/A | N/A | N/A | | | Details |
| 11/8/10 |
|
Q310 | -$0.11 | -$0.09 | -$0.02 | N/A | N/A | N/A | | | Details |
